Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis.
Carpal tunnel syndrome (CTS) has been associated with amyloid deposits and is now regarded as a major complication in chronic hemodialysis patients. While this new syndrome has been receiving increasing attention, its etiology has not been clarified. We have isolated amyloid fibrils from amyloid laden tissues inside the carpal tunnel in four different hemodialysis patients with CTS. After solubilization in guanidine HCl, a significant amount of the protein was located in a homogeneous, low molecular weight fraction. Each protein was found to be identical to beta 2-microglobulin with regard to its molecular weight of 11,000 on SDS-PAGE, amino acid composition and N-terminal amino acids: Ile-Gln-Arg-Thr-Pro-Lys-Ile-Gln-Val-Tyr-Ser-Arg-His-Pro-Ala-Glu. In direct immunofluorescent study, anti-beta 2-microglobulin did react positively with amyloid deposits. These results demonstrate that the amyloid associated with chronic hemodialysis contains as major component a new form of amyloid fibril protein that is homologous to beta 2-microglobulin. It is postulated that beta 2-microglobulin cannot be removed from the blood by conventional hemodialysis, and accumulates in tissues causing the formation of amyloid fibrils, which, having a relatively high affinity to the carpal tunnel area, thus causes CTS.
D000596:Amino Acids / Q000032:analysis; D000686:Amyloidosis / Q000150:complications / Q000209:etiology / Q000378:metabolism; D002349:Carpal Tunnel Syndrome / Q000209:etiology / Q000378:metabolism; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D008970:Molecular Weight; D006435:Renal Dialysis / Q000009:adverse effects*; D000685:Serum Amyloid A Protein / Q000032:analysis / Q000378:metabolism*; D001613:beta 2-Microglobulin / Q000032:analysis / Q000378:metabolism*
D000596:Amino Acids; D000685:Serum Amyloid A Protein; D001613:beta 2-Microglobulin